Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Shares Issued (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Shares Issued for 13 consecutive years, with $746000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 370.29% to $746000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $766000.0 through Dec 2025, up 237.44% year-over-year, with the annual reading at $766000.0 for FY2025, 673.74% up from the prior year.
  • Shares Issued for Q4 2025 was $746000.0 at Theravance Biopharma, up from $20000.0 in the prior quarter.
  • The five-year high for Shares Issued was $108.2 million in Q3 2021, with the low at -$276000.0 in Q4 2024.
  • Average Shares Issued over 5 years is $10.0 million, with a median of $20000.0 recorded in 2025.
  • Peak annual rise in Shares Issued hit 33200.0% in 2024, while the deepest fall reached 259.54% in 2024.
  • Over 5 years, Shares Issued stood at $108.2 million in 2021, then crashed by 99.71% to $314000.0 in 2022, then crashed by 44.9% to $173000.0 in 2023, then crashed by 259.54% to -$276000.0 in 2024, then soared by 370.29% to $746000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $746000.0, $20000.0, and -$276000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.